[144] Leonardo DRS, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Leonardo DRS (DRS) discloses a proposed sale of 11,375 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $468,308.75. The filing lists approximately 266,123,634 shares outstanding and an approximate sale date of 08/20/2025. The shares were acquired on 03/15/2023 through restricted stock vesting and were received as compensation. The filer reports no securities sold in the past three months and includes the standard representation that the seller does not possess undisclosed material adverse information.

Positive

• Compliance with Rule 144 is clearly documented, including broker and sale information
• Shares originated from restricted stock vesting, indicating the sale is tied to compensation rather than an acquisition or external transfer

Negative

• None.

Insights

Financial Analyst

TL;DR: Small, routine insider sale notice; limited immediate market impact given size versus total shares outstanding.

The Form 144 records a proposed disposition of 11,375 shares valued at $468,308.75. Against the reported 266,123,634 shares outstanding, this represents a de minimis fraction of the float, indicating the filing is likely procedural compliance following equity vesting rather than a signal of material insider-driven liquidity events. The absence of other sales in the past three months reduces near-term pattern concerns. Investors should note this is a notice of intent to sell under Rule 144, not confirmation of executed trades.

Corporate Governance Expert

TL;DR: Filing reflects standard post-vesting disclosure and adherence to Rule 144 requirements; governance risk is low.

The disclosure shows shares were acquired through restricted stock vesting and will be offered via a broker. This is typical for equity compensation exits and aligns with customary disclosure obligations. The filer’s representation regarding lack of undisclosed material information is standard. There are no governance red flags such as concentrated sales, accelerated disposition schedules, or multiple recent disposals reported in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	11375	468308.75	266123634	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2023	Restricted Stock Vesting	Issuer			11375	03/15/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for DRS disclose?

The filing discloses a proposed sale of 11,375 common shares valued at $468,308.75, with an approximate sale date of 08/20/2025.

How were the DRS shares acquired that are being sold?

The shares were acquired on 03/15/2023 through restricted stock vesting and were received as compensation.

Who is the broker named in the DRS Form 144?

The broker listed is Fidelity Brokerage Services LLC at the address provided in the filing.

Has the filer sold other DRS securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Does the Form 144 indicate undisclosed material information about DRS?

The filer represents by signature that they do not know of any material adverse information not publicly disclosed.